Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Rash started in back of neck and is now all over body and feet/it is still ongoing; This non-serious case was reported by a consumer via call center representative and described the occurrence of generalized rash in a 2-year-old female patient who received Hepatitis B vaccine for prophylaxis. In FEB-2025, the patient received Hepatitis B vaccine. In FEB-2025, between 2 and 3 weeks after receiving Hepatitis B vaccine, the patient experienced generalized rash (Verbatim: Rash started in back of neck and is now all over body and feet/it is still ongoing). The outcome of the generalized rash was not resolved. It was unknown if the reporter considered the generalized rash to be related to Hepatitis B vaccine. It was unknown if the company considered the generalized rash to be related to Hepatitis B vaccine. Additional Information: GSK receipt date: 30-MAY-2025 The grandmother of the patient reported the patient received a Hepatitis B vaccine in February 2025 and 2 and a half weeks later she noticed a rash in the back of the neck. The rash later traveled to face and is now all over her body including feet. They took her to several doctors. She did not want to provide heath care professional consent. The reporter would call back with the name of the vaccine.